Feasibility Study of Umbilical Cord Tissue Derived Mesenchymal Stem Cells (UC-MSC) in Disease Modifying Anti-Rheumatic Drugs (DMARD) Resistant Rheumatoid Arthritis
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Cord blood stem cell therapy (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Translational Biosciences
- 19 Jun 2019 Status changed from recruiting to active, no longer recruiting.
- 18 Oct 2018 Status changed from active, no longer recruiting to recruiting.
- 10 Sep 2018 Planned End Date changed from 1 Feb 2019 to 1 Jun 2020.